Holen Sie sich die Stockscreener-App
85.48
1.14%
0.96
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$84.52
Offen:
$84.14
24-Stunden-Volumen:
4.37M
Relative Volume:
0.67
Marktkapitalisierung:
$68.90B
Einnahmen:
$20.10B
Nettoeinkommen (Verlust:
$3.04B
KGV:
23.95
EPS:
3.569
Netto-Cashflow:
$3.44B
1W Leistung:
+3.04%
1M Leistung:
+9.09%
6M Leistung:
-1.57%
1J Leistung:
-3.62%
1-Tages-Spanne:
$83.56
$85.56
1-Wochen-Bereich:
$83.03
$85.56
52-Wochen-Spanne:
$74.55
$100.18
Colgate Palmolive Co Stock (CL) Company Profile
Firmenname
Colgate Palmolive Co
Sektor
Telefon
(212) 310-2000
Adresse
300 PARK AVE, NEW YORK, NY
Vergleichen Sie CL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CL
Colgate Palmolive Co
|
85.48 | 68.13B | 20.10B | 3.04B | 3.44B | 3.569 |
|
PG
Procter Gamble Co
|
146.85 | 337.73B | 84.93B | 16.86B | 14.94B | 6.8506 |
|
UL
Unilever Plc Adr
|
64.81 | 140.68B | 64.99B | 6.71B | 6.53B | 2.74 |
|
EL
Estee Lauder Cos Inc
|
114.00 | 41.46B | 14.42B | -930.00M | 1.05B | -2.5832 |
|
KMB
Kimberly Clark Corp
|
101.05 | 32.96B | 18.08B | 1.81B | 1.67B | 5.904 |
Colgate Palmolive Co Stock (CL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-13 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2026-01-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-12-11 | Herabstufung | Argus | Buy → Hold |
| 2025-12-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-10-03 | Fortgesetzt | Piper Sandler | Neutral |
| 2024-10-28 | Herabstufung | Stifel | Buy → Hold |
| 2024-09-24 | Eingeleitet | Piper Sandler | Overweight |
| 2024-09-16 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-09-09 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-07-26 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2024-07-23 | Eingeleitet | TD Cowen | Buy |
| 2024-06-24 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2024-03-01 | Fortgesetzt | Goldman | Buy |
| 2024-01-29 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-12-15 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-11-13 | Eingeleitet | Jefferies | Buy |
| 2023-10-16 | Hochstufung | Stifel | Hold → Buy |
| 2023-09-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-02-17 | Eingeleitet | Citigroup | Buy |
| 2023-01-30 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-11-22 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-10-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-08-01 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-05-03 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-04-08 | Eingeleitet | Raymond James | Mkt Perform |
| 2022-02-02 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2022-01-31 | Bestätigt | Citigroup | Neutral |
| 2022-01-31 | Bestätigt | Credit Suisse | Outperform |
| 2022-01-31 | Bestätigt | Deutsche Bank | Buy |
| 2022-01-31 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-01-31 | Bestätigt | Wells Fargo | Underweight |
| 2021-12-16 | Eingeleitet | Redburn | Neutral |
| 2021-10-05 | Fortgesetzt | BofA Securities | Neutral |
| 2021-09-20 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-06-24 | Eingeleitet | UBS | Buy |
| 2021-06-09 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-02-01 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2021-01-28 | Herabstufung | Stifel | Buy → Hold |
| 2021-01-26 | Hochstufung | Berenberg | Sell → Hold |
| 2021-01-20 | Eingeleitet | Bernstein | Underperform |
| 2021-01-04 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-12-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-07-22 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-03-27 | Hochstufung | Stifel | Hold → Buy |
| 2020-03-27 | Hochstufung | SunTrust | Hold → Buy |
| 2020-03-23 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-03-20 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-02-03 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2020-02-03 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-12-19 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-10-16 | Eingeleitet | Berenberg | Sell |
| 2019-04-29 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2019-03-07 | Eingeleitet | Credit Suisse | Underperform |
| 2019-02-11 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2019-01-11 | Eingeleitet | Evercore ISI | Outperform |
| 2019-01-09 | Hochstufung | Goldman | Neutral → Buy |
| 2018-10-29 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-10-26 | Herabstufung | SunTrust | Buy → Hold |
| 2018-07-30 | Herabstufung | Macquarie | Outperform → Neutral |
| 2018-05-25 | Hochstufung | Argus | Hold → Buy |
| 2018-04-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
Alle ansehen
Colgate Palmolive Co Aktie (CL) Neueste Nachrichten
Ex-Dividend Reminder: Colgate-Palmolive, Lowe's Companies and CVS Health - Nasdaq
3.7 billion affected by oral disease; Colgate backs 4-year WHO campaign - Stock Titan
Colgate-Palmolive India Schedules Board Meeting for January 29, 2026 to Approve Q3FY26 Financial Results - scanx.trade
Barclays Raises Colgate (CL) Target to $83 but Stays Cautious on Fundamentals - Finviz
Market Trading Guide: Buy Ashok Leyland, Polycab India and 2 more stocks on Tuesday for up to 12% upside - The Economic Times
Campbell & CO Investment Adviser LLC Buys New Holdings in Colgate-Palmolive Company $CL - MarketBeat
The Truth About Colgate-Palmolive: Why Everyone Is Suddenly Watching This ‘Boring’ Stock - AD HOC NEWS
Colgate-Palmolive Co (CL) Stock Price, Trades & News - GuruFocus
JP Morgan Raises Price Target for Colgate-Palmolive (CL) to $93 - GuruFocus
Colgate-Palmolive (NYSE:CL) Price Target Raised to $93.00 at JPMorgan Chase & Co. - MarketBeat
Colgate-Palmolive to stream 2025 earnings call investors can replay - Stock Titan
Household Products Stocks Q3 Teardown: Colgate-Palmolive (NYSE:CL) Vs The Rest - Finviz
Colgate-Palmolive Company $CL Stake Raised by Alliance Wealth Management Group - MarketBeat
Colgate-Palmolive flosses away dental care shadows to reveal 'the sweet truth' - Campaign India
$332M Colgate-Palmolive Pension Deal Nabs Final Nod - Law360
Colgate-Palmolive Cleared for $332 Million Pension Class Deal - Bloomberg Law News
Manning & Napier Advisors LLC Sells 35,021 Shares of Colgate-Palmolive Company $CL - MarketBeat
Palmolive Duschgel Review: The Surprisingly Affordable Shower Upgrade Everyone’s Sleeping On - AD HOC NEWS
UBS Maintains Colgate-Palmolive (CL) Rating and Raises Price Tar - GuruFocus
TD Cowen is Bullish on Colgate-Palmolive Company (CL) - Finviz
Colgate-Palmolive (NYSE:CL) Upgraded to Equal Weight at Wells Fargo & Company - MarketBeat
Ranking of most iconic U.S. companies includes 3 in Ohio - Cleveland.com
TD Private Client Wealth LLC Has $2.93 Million Stock Position in Colgate-Palmolive Company $CL - MarketBeat
Is Colgate (CL) Turning Emerging-Market Social Impact Into a Durable Brand and Margin Advantage? - simplywall.st
Colgate-Palmolive’s Integrated CSR and ESG Initiatives Create an Impact on Health, Dignity and Community Well-Being - The Hindu
Wells Fargo Upgrades Colgate-Palmolive (CL) - Nasdaq
Analysts See Value Emerging in Colgate-Palmolive Shares - AD HOC NEWS
Demystifying Colgate-Palmolive: Insights From 13 Analyst Reviews - Benzinga
7 Best Beauty Stocks to Buy Right Now - Insider Monkey
Is Colgate's Cost Discipline Enough in a Softer Demand Cycle? - Nasdaq
Colgate-Palmolive emerges from difficult 2025 with a balanced risk/reward -- Wells Fargo (CL:NYSE) - Seeking Alpha
Colgate-Palmolive (CL): Wells Fargo Upgrades to Equal-Weight wit - GuruFocus
Liberty One Investment Management LLC Has $6.48 Million Position in Colgate-Palmolive Company $CL - MarketBeat
Colgate-Palmolive's Integrated CSR and ESG Initiatives Create an Impact on Health, Dignity and Community Well-Being - Business Standard
Nordea Investment Management AB Lowers Position in Colgate-Palmolive Company $CL - MarketBeat
Sumitomo Mitsui Trust Group Inc. Purchases 38,836 Shares of Colgate-Palmolive Company $CL - MarketBeat
Wells Fargo Upgrades Colgate-Palmolive to Equalweight From Underweight, Adjusts PT to $86 From $77 - marketscreener.com
Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Has $6.48 Million Stake in Colgate-Palmolive Company $CL - MarketBeat
Towercrest Capital Management Boosts Stock Position in Colgate-Palmolive Company $CL - MarketBeat
Colgate Sensation White Review: The Everyday Toothpaste That Wants to Be Your At?Home Whitening Hack - AD HOC NEWS
Another class action claims Tom’s of Maine toothpaste contaminated with bacteria - Class Action Lawsuits
Piper Sandler Sees Colgate (CL) Reaccelerating in 2026, Lifts Price Target - Finviz
Sumitomo Mitsui DS Asset Management Company Ltd Purchases 27,943 Shares of Colgate-Palmolive Company $CL - MarketBeat
Oregon Public Employees Retirement Fund Has $7.39 Million Stock Position in Colgate-Palmolive Company $CL - MarketBeat
An HR exec at $62 billion giant Colgate says Gen Zers are actually ‘pushing us to get better’ - Fortune
Colgate-Palmolive Western Europe legal director Barbara Naouri on resilience, AI and assessing external counsel - Legal Business
Is Colgate-Palmolive (CL) Pricing Reflect Its Consumer Staples Resilience? - Yahoo Finance
Colgate-Palmolive Company $CL Shares Purchased by Commonwealth Equity Services LLC - MarketBeat
Will Colgate Palmolive Company stock split again soonEarnings Performance Report & Scalable Portfolio Growth Methods - Улправда
How Colgate Palmolive Company stock performs during Fed tightening cyclesJuly 2025 PostEarnings & Target Return Focused Picks - ulpravda.ru
Moving Averages: How Colgate Palmolive Company stock performs during Fed tightening cyclesJuly 2025 PostEarnings & Target Return Focused Picks - Улправда
Finanzdaten der Colgate Palmolive Co-Aktie (CL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.71%
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):